Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Kenneth S. Abramowitz is a co-founder and Managing General Partner of NGN Capital, a worldwide healthcare venture capital fund. He has a background as a healthcare analyst and has served on the boards of several companies in the healthcare and biotechnology sectors. Abramowitz is also known for his involvement in pro-Israel and conservative organizations, and is the founder of SaveTheWest.com, a website focused on Western civilization and national security. He is the author of "The Multifront War: Defending America From Political Islam, China, Russia, Pandemics, and Racial Strife."
Portfolio
No portfolio companies in this dataset yet.
Investment activity
1 portfolio exit on record.
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Kenneth Abramowitz's primary investment focus by sector?
- Kenneth Abramowitz primarily focuses on the Health Tech & Life Sciences sector, with one recorded investment and one exit in this area.
- Has Kenneth Abramowitz had any notable exits?
- Yes, Kenneth Abramowitz had an exit in July 2018 when portfolio company Entera Bio went public on NASDAQ with a valuation of $91M, having raised $11M in capital.
- What is Kenneth Abramowitz's most notable portfolio company?
- Kenneth Abramowitz's most notable portfolio company is Entera Bio, which specializes in the oral delivery of therapeutic proteins and went public in July 2018.
- What is Kenneth Abramowitz's investment stage preference?
- Kenneth Abramowitz has participated in Seed stage investments, with one recorded instance.
- When was Kenneth Abramowitz's most recent investment activity?
- Kenneth Abramowitz's most recent recorded investment activity was in February 2014.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Radar intelligence
Patents
| EPO | 1 |
|---|